Home > Products > CD20 & CD47 > Human Anti-CD20 x Anti-CD47 Bispecific Antibody (IgG-IgG)

Human Anti-CD20 x Anti-CD47 Bispecific Antibody (IgG-IgG)  (CAT#: BSIG-H227)

Anti-CD20 x Anti-CD47 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD20 and anti-CD47 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Lymphoma therapy.
Product datasheet PDF document Datasheet INQUIRY
Product type illustration

Specifications

Targets
CD20 & CD47
Type
IgG-IgG
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Lymphoma
Host Animal 1
Human
Host Animal 2
Human

Targets

Target 1
CD20
Gene ID
UniProt ID
Alternative Names
MS4A1; membrane-spanning 4-domains, subfamily A, member 1; B1; S7; Bp35; CD20; CVID5; MS4A2; LEU-16; B-lymphocyte antigen CD20; CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16; B-lymphocyte cell-surface antigen B1
Target 2
CD47
Gene ID
UniProt ID
Alternative Names
CD47; CD47 molecule; IAP; OA3; MER6; leukocyte surface antigen CD47; CD47 glycoprotein; Rh-related antigen; integrin associated protein; integrin-associated protein; integrin-associated signal transducer; antigenic surface determinant protein OA3; antigen identified by monoclonal antibody 1D8; CD47 antigen (Rh-related antigen, integrin-associated signal transducer)
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD20 & CD47"
See other bsAb targets related to "CD47"

See other bsAb targets related to "CD20"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Human Anti-CD20 x Anti-CD47 Bispecific Antibody (IgG-IgG) (BSIG-H227). Click the button below to contact us or submit your feedback about this product.

Facebook LinkedIn Twitter Blogger YouTube